S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
With oil prices slumping, OPEC+ producers weigh more production cuts
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
With oil prices slumping, OPEC+ producers weigh more production cuts
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
With oil prices slumping, OPEC+ producers weigh more production cuts
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
With oil prices slumping, OPEC+ producers weigh more production cuts
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
NASDAQ:BRKR

Bruker (BRKR) Stock Forecast, Price & News

$71.39
+0.45 (+0.63%)
(As of 06/2/2023 ET)
Compare
Today's Range
$70.36
$71.77
50-Day Range
$69.10
$84.02
52-Week Range
$48.42
$84.84
Volume
629,268 shs
Average Volume
883,171 shs
Market Capitalization
$10.47 billion
P/E Ratio
34.00
Dividend Yield
0.28%
Price Target
$84.50

Bruker MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
18.4% Upside
$84.50 Price Target
Short Interest
Healthy
3.11% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.48
Upright™ Environmental Score
News Sentiment
0.52mentions of Bruker in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$26.69 M Sold Last Quarter
Proj. Earnings Growth
12.02%
From $2.58 to $2.89 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.81 out of 5 stars

Computer And Technology Sector

34th out of 609 stocks

Analytical Instruments Industry

2nd out of 27 stocks


BRKR stock logo

About Bruker (NASDAQ:BRKR) Stock

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The BSI CALID segment includes the design and distribution of life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological/nuclear detectors for Chemical, Biological, Radiological, Nuclear and Explosive (CBRNE) detection. The BSI Nano segment offers x-ray instruments that use electromagnetic radiation with wavelengths to determine the characteristics of matter and the three-dimensional (3D) structure of molecules. The BEST segment consist

Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

BRKR Stock News Headlines

Bruker to Host Investor Day on June 15th, 2023
How A.I. Could Make Most 21st Century Diseases EXTINCT
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
Bruker goes ex dividend tomorrow
Bruker (NASDAQ:BRKR) Shares Gap Down to $73.12
How A.I. Could Make Most 21st Century Diseases EXTINCT
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
8-K: BRUKER CORP
Bruker Co. (NASDAQ:BRKR) CEO Sells $1,301,816.35 in Stock
See More Headlines

BRKR Price History

BRKR Company Calendar

Ex-Dividend for 3/17 Dividend
2/28/2023
Dividend Payable
3/17/2023
Last Earnings
5/04/2023
Ex-Dividend for 6/16 Dividend
5/31/2023
Today
6/04/2023
Dividend Payable
6/16/2023
Next Earnings (Estimated)
8/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:BRKR
CUSIP
11679410
Employees
8,525
Year Founded
1960

Price Target and Rating

Average Stock Price Forecast
$84.50
High Stock Price Forecast
$98.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+18.4%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$296.60 million
Pretax Margin
16.27%

Debt

Sales & Book Value

Annual Sales
$2.62 billion
Cash Flow
$2.99 per share
Book Value
$8.17 per share

Miscellaneous

Free Float
106,211,000
Market Cap
$10.47 billion
Optionable
Optionable
Beta
1.16

Social Links


Key Executives

  • Frank H. LaukienFrank H. Laukien
    Chairman, President & Chief Executive Officer
  • Gerald N. Herman
    Chief Financial Officer & Executive Vice President
  • Mark Robert Munch
    Executive Vice President
  • Jürgen Srega
    Group President-Bruker CALID Segment
  • Falko Busse
    President-Bruker BioSpin Group













BRKR Stock - Frequently Asked Questions

Should I buy or sell Bruker stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" BRKR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRKR, but not buy additional shares or sell existing shares.
View BRKR analyst ratings
or view top-rated stocks.

What is Bruker's stock price forecast for 2023?

3 equities research analysts have issued 1 year price objectives for Bruker's stock. Their BRKR share price forecasts range from $70.00 to $98.00. On average, they expect the company's share price to reach $84.50 in the next twelve months. This suggests a possible upside of 18.4% from the stock's current price.
View analysts price targets for BRKR
or view top-rated stocks among Wall Street analysts.

How have BRKR shares performed in 2023?

Bruker's stock was trading at $68.35 on January 1st, 2023. Since then, BRKR stock has increased by 4.4% and is now trading at $71.39.
View the best growth stocks for 2023 here
.

Are investors shorting Bruker?

Bruker saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 3,060,000 shares, a decline of 18.2% from the April 30th total of 3,740,000 shares. Based on an average daily volume of 858,300 shares, the days-to-cover ratio is currently 3.6 days. Currently, 3.1% of the shares of the stock are short sold.
View Bruker's Short Interest
.

When is Bruker's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our BRKR earnings forecast
.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) posted its quarterly earnings results on Thursday, May, 4th. The medical research company reported $0.64 EPS for the quarter, topping analysts' consensus estimates of $0.55 by $0.09. The medical research company earned $685.30 million during the quarter, compared to analysts' expectations of $639.63 million. Bruker had a net margin of 11.89% and a trailing twelve-month return on equity of 34.71%. The company's quarterly revenue was up 15.2% on a year-over-year basis. During the same quarter last year, the business posted $0.49 EPS.

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Thursday, May 11th. Investors of record on Thursday, June 1st will be paid a dividend of $0.05 per share on Friday, June 16th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date is Wednesday, May 31st.
Read our dividend analysis for BRKR
.

Is Bruker a good dividend stock?

Bruker (NASDAQ:BRKR) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.29%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 9.52%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BRKR will have a dividend payout ratio of 6.92% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BRKR.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of $2.55-$2.60 for the period, compared to the consensus EPS estimate of $2.56. The company issued revenue guidance of $2.83 billion-$2.88 billion, compared to the consensus revenue estimate of $2.82 billion.

What is Frank H. Laukien's approval rating as Bruker's CEO?

126 employees have rated Bruker Chief Executive Officer Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among the company's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend.

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (7.49%), FMR LLC (7.41%), State Street Corp (2.26%), Price T Rowe Associates Inc. MD (1.83%), Geode Capital Management LLC (1.15%) and Brown Advisory Inc. (1.08%). Insiders that own company stock include Cynthia M Friend, Frank H Laukien, Marc A Kastner, Mark Munch and Richard A Packer.
View institutional ownership trends
.

How do I buy shares of Bruker?

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $71.39.

How much money does Bruker make?

Bruker (NASDAQ:BRKR) has a market capitalization of $10.47 billion and generates $2.62 billion in revenue each year. The medical research company earns $296.60 million in net income (profit) each year or $2.10 on an earnings per share basis.

How many employees does Bruker have?

The company employs 8,525 workers across the globe.

Does Bruker have any subsidiaries?
The following companies are subsidiares of Bruker: Accel Instruments, Advances Diagnostic Solutions Pty. Ltd., Agapetus GmbH, Alicona Corporation, Alicona GmbH, Alicona Imaging, Alicona Imaging GmbH, Alicona Korea Pcific Ltd., Alicona Manufacturing Inc., Alicona SARL, Alicona UK Limited, Alicona s.r.l., Anasys Instruments Corporation, Anasys Instruments GmbH, Arxspan, Biocentra AS., Bruker (Beijing) Scientific Technology Co. Ltd., Bruker (Malaysia) SDN BHD, Bruker AXS GmbH, Bruker AXS Handheld Inc., Bruker AXS LLC, Bruker AXS Ltd., Bruker Advanced Supercon GmbH, Bruker Austria GmbH, Bruker Belgium S.A./N.V., Bruker BioSciences Securities Corporation, Bruker BioSpin AG, Bruker BioSpin Corporation, Bruker BioSpin GmbH, Bruker BioSpin K.K., Bruker BioSpin MRI GmbH, Bruker Business Support Center sp. z o.o, Bruker Daltonics GmbH, Bruker Daltonics Ltd., Bruker Daltonics Pty. Ltd., Bruker Daltonics S.r.l., Bruker Daltonik GmbH, Bruker Detection Corporation, Bruker EAS GmbH, Bruker Energy & Supercon Technologies Inc. , Bruker Espanola S.A., Bruker Finance B.V., Bruker France S.AS., Bruker HTS GmbH, Bruker India Scientific PVT Ltd., Bruker Invest AG, Bruker Italia S.r.l., Bruker JV Israel Ltd., Bruker JV UK Ltd., Bruker Korea Co. Ltd., Bruker Ltd., Bruker Mexicana S.A. de C.V., Bruker MicroCT N.V., Bruker Nano GmbH, Bruker Nano Inc., Bruker Nederland B.V., Bruker Nordic AB, Bruker OST LLC, Bruker Optics GmbH, Bruker Optics Inc. , Bruker Optik GmbH, Bruker PTY Ltd., Bruker Physik GmbH, Bruker Polska Sp. Z o.o., Bruker Portugal Unipessoal LDA, Bruker Scientific Instruments Hong Kong Co. Ltd., Bruker Scientific Israel Ltd., Bruker Scientific LLC, Bruker Singapore Pte. Ltd., Bruker South Africa (Pty) Ltd., Bruker Taiwan Co. Ltd., Bruker Turkey Teknolojik Sistemler Ticaret Ltd. Sirketi, Bruker UK Ltd., Bruker do Brasil Ltda., Bruker s.r.o., Hain LifeScience E.A. Ltd., Hain LifeScience GmbH, Hain LifeScience Solutions (Pty) Ltd., Hain LifeScience Spain S.L., Hain LifeScience UK Ltd., Hain LifeSciences S.A. Pty Ltd., Hydrostatic Extrusions Ltd., Hysitron, InCoaTec GmbH, InVivo Biotech Services GmbH, InVivo Biotech Svs GmbH, JPK Instruments Limited, JPK Instruments USA. Inc., JPK In­stru­ments, JUWE Laborgeraete, Jordan Valley Semiconductors, Keymaster Technologies, Luxendo, Luxendo GmbH, MAC Science, Merlin Diagnostika GmbH, Mestrelab Research S.L., Michrom Bioresources, Oncovision - Innovative Medical Imaging, PMOD Technologies, Prairie Technologies, Princeton Gamma-Tech Instruments Inc, Quantron, RI Research Instruments GmbH, Roentec AG, S.I.S. Surface Imaging Systems, SAS Biocentric, SCiLS GmbH, SkyScan, Socabim, VACUUMSCHMELZE GmbH & Co. KG, Vutara LLC, XGLabs S.r.l., and Yingsheng Technology.
Read More
How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The official website for the company is www.bruker.com. The medical research company can be reached via phone at (978) 663-3660, via email at investor.relations@bruker.com, or via fax at 978-663-5585.

This page (NASDAQ:BRKR) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -